CNTB Connect Biopharma Holdings Net earnings per share growth forecast for next year
The absence of commercial products leads to constant R&D expenditures, which precludes cash flow predictability. Analyst expectations for N+1 profit dynamics clearly demonstrate this process, where the value of 20.10 describes the current level. The financial success of Connect Biopharma (CNTB) depends on regulators, while the company actively validates innovative small molecules for the therapy of autoimmune pathologies.
Metric breakdowns and analytics for Connect Biopharma Holdings Limited (CNTB)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Debt to Equity Connect Biopharma|CNTB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Connect Biopharma Holdings|CNTB - Company Aggregate Debt|Debt to Book Capitalization Ratio Connect Biopharma|CNTB - Company Long-Term Indebtedness|Company Short-Term Debts Connect Biopharma|Quick Ratio connectbiopharm.com
- earnings and valuation multiples information:
CNTB - Net Income|Future Profit Connect Biopharma|CNTB - Market Price to Net Income Ratio|Projected Price to Earnings Connect Biopharma Holdings|CNTB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Connect Biopharma|CNTB - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Connect Biopharma|CNTB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months connectbiopharm.com|CNTB - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Connect Biopharma
General company analysis:CNTB, Connect Biopharma
This indicator measures the percentage change in expected earnings per share, reflecting the expert consensus forecast for the business's future profitability. By analyzing the one-year forward EPS growth rate, an investor assesses the asset's valuation sensitivity to analysts' revisions of financial plans. For Connect Biopharma (CNTB), the metric's trend depends directly on the success of late-stage clinical trials for dermatitis therapies in the US and China.
Competing companies
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Grifols Biemat (GRFS) - Expected earnings per share growth for next year|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year celldex.com (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharmaceuticals Inc.|Projected earnings per share growth rate for next year BCRX (BioCryst Pharmaceuticals, Inc.)|Net earnings per share growth forecast for next year Vera Pharma (VERA)|Dianthus Corp - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|abcellera.com (ABCL) - Expected net earnings per share growth next year|Tourmaline Bio - Earnings growth forecast for next year|Precigen Inc (PGEN) - Expected earnings per share growth for next year|PHAR (Pharming) - Expected earnings per share growth for next year|NKTR: Projected earnings per share increase next year|Expected earnings per share growth for next year UPB|ZBIO: Expected earnings per share trend next year|Earnings growth forecast for next year IMNM|Net earnings per share growth forecast for next year GOSS (Gossamer Bio Inc)|Earnings growth forecast for next year KALV (KalVista Pharmaceuticals Inc)|Consensus forecast of earnings per share growth for next year Septerna Pharma (SEPN)|PVLA - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year savarapharma.com|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year ANAB (AnaptysBio Inc)|ATXS (Astria Pharma) - Earnings growth forecast for next year|ENGN: Expected earnings per share trend next year|Earnings growth forecast for next year RAPT|Earnings growth forecast for next year aerovatetx.com (JBIO)|Net earnings per share growth forecast for next year Aclaris Therapeutics, Inc. ACRS|Expected earnings per share trend next year KYTX|TLSA - Net earnings per share growth forecast for next year|Cabaletta Bio Inc (CABA) - Expected earnings per share growth for next year|VTYX: Earnings growth forecast for next year|theratech.com (THTX) - Earnings growth forecast for next year|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|Expected earnings per share growth for next year Eledon Pharmaceuticals Inc. (ELDN)|Net earnings per share growth forecast for next year Agenus Inc (AGEN)|Climb Bio, Inc - Projected earnings per share growth rate for next year|Zura Bio Limited - Expected earnings per share growth for next year|Projected earnings per share increase next year ATYR (atyrpharma.com)|Adagene Corp - Earnings growth forecast for next year|IMA: Net earnings per share growth forecast for next year|shattucklabs.com (STTK) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year EQ (Equillium)|IMUX (Immunic Therapeutics) - Earnings growth forecast for next year|ATRA: Expected earnings per share trend next year|Earnings growth forecast for next year IFRX|Earnings growth forecast for next year X4 Pharmaceuticals Inc. (XFOR)|Net earnings per share growth forecast for next year Adicet Bio, Inc. ACET|Expected earnings per share trend next year CELU|INMB - Net earnings per share growth forecast for next year|barinthusbio.com (BRNS) - Expected earnings per share growth for next year|KZR: Earnings growth forecast for next year|SAB Biotherapeutics Inc. (SABS) - Earnings growth forecast for next year|Expected earnings per share growth for next year AKTX|ENLV: Expected earnings per share trend next year|Earnings growth forecast for next year QTTB|Consensus forecast of earnings per share growth for next year geovax.com|Net earnings per share growth forecast for next year Edesa Biotech EDSA|IBIO - Expected earnings per share growth for next year|CARM - Net earnings per share growth forecast for next year|XTL Bio (XTLB) - Expected earnings per share growth for next year|BOLT (boltbio.com) - Expected earnings per share growth for next year|HCW Biologics (HCWB) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Projected earnings per share growth rate for next year AIM (AIM ImmunoTech, Inc.)|Earnings growth forecast for next year ADTX|GRI - Expected net earnings per share growth next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc.)|HIND - Expected earnings per share growth for next year|REVB - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Indaptus Therapeutics Inc|Scinai (SCNI) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year CALI|Net earnings per share growth forecast for next year Affimed NV|Projected earnings per share growth rate for next year ALLK (Allakos Therapeutics)|Earnings growth forecast for next year HOOK|IGMS - Expected net earnings per share growth next year|Earnings growth forecast for next year ITOS (iTeos)|OCEA - Expected earnings per share growth for next year|TCBP: Expected earnings per share growth for next year|thirdharmonicbio.com - Projected earnings per share increase next year
